Nanotech Investing: World

Coverage of the nanotech market for global investors, including news, analysis forecasts, and stock updates.

Latest Articles
Company Profiles
More Companies
CEO Interviews
Badge
Sona Nanotech
Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics
SPONSORED/ Sona Nanotech

Sona Nanotech Touts "Superior" Results from Animal Study for Cancer Therapy, Eyes In-human Study

Nanotech Investing

Sona Nanotech CEO Sees Huge Market Potential for Nano-based Cancer Therapies

Nanotech Investing

Nano Dimension’s Amit Dror

CEO Interviews
nanotech News

Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference

Technology Investing

Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal

Technology Investing

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Technology Investing

Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update

Technology Investing

Sona Nanotech Issued Patent and Appoints New Board Member

Technology Investing
Sona Nanotech (CSE:SONA)

Sona Nanotech Grants Options

Nanotech Investing

Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds

Technology Investing

Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing

Technology Investing
Sona Nanotech (CSE:SONA)

Sona Nanotech to Arrange Private Placement Financing

Technology Investing
Sona Nanotech (CSE:SONA)

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Technology Investing

Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Technology Investing

Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024

Nanotech Investing

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Nanotech Investing

Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor

Nanotech Investing

Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers

Nanotech Investing
More nanotech News
Editors' Picks

Latest nanotech News

More nanotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES